PROCESSO PER LA PURIFICAZIONE DI FORME MUTATE MONOMETRICHE DEL FATTORENEURONOTROFICO CILIARE UMANO

摘要

This invention relates to a process for the purification of biologically active mutated monomer forms of human ciliary growth factor (CNTF) for the preparation of pharmaceutical formulations for use for the prevention and/or recovery of nervous function in the peripheral and central nervous system under acute or chronic traumatic and pathological conditions.